Atty Lies Shouldn't Doom $200M IP Win, Merck Tells Justices
By Kevin Penton ( September 25, 2018, 11:07 PM EDT) -- Merck has asked the U.S. Supreme Court to review the Federal Circuit's upholding of a decision that wiped out a $200 million patent verdict it won against Gilead over hepatitis C drugs after an in-house attorney purportedly exhibited "dishonest and duplicitous" behavior....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.